Richard Vaglienti, MD
Pain Medicine · Morgantown, WVNPI 1861592669
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,500 of the $12,989 with a category attached, or 65.4%. 4 manufacturers reported payments, led by Medtronic at 57.9% of the total. Reporting peaked in 2019 at $5,602 and has fallen 83.5% since, to $926 in 2025.
Across 58 payments — averaging $223.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Boston Scientific$5K
- Nevro Corp.$651
- Vertos Medical, Inc.$118
Across 3 payments — averaging $17,552 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$53K
What the payments were for
- Speaking & faculty fees$8,50065%
- Travel & lodging$1,2129%
- Food & beverage$3,27725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 39 | $7,527 |
| Boston Scientific | 7 | $4,694 |
| Nevro Corp. | 11 | $651 |
| Vertos Medical, Inc. | 1 | $118 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSphere Y90 Glass Microspheres 10 GBq$4,250
- ADAPTIVESTIM$2,121
- LIORESAL$2,000
- INTELLIS$1,349
- INTELLIS ADAPTIVESTIM$407
- INCEPTIV$405
- Senza$270
- VECTRIS SURESCAN$241
- GENERAL DBS$125
- MYSTIM$122
- mild Device Kit$118
- VANTA ADAPTIVESTIM$117
How this compares
$12,989 in reported general payments places this provider in the 85th percentile of 35 pain medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 150 | $3,535 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 106 | $2,687 |
| Oxycodone Hcl | 66 | $1,650 |
| Fentanyl | 16 | $1,290 |
| Gabapentin | 62 | $382 |
| Tizanidine Hcl | 37 | $317 |
| Duloxetine Hcl | 31 | $229 |
| Pregabalin | 19 | $195 |
| Baclofen | 11 | $152 |
| Meloxicam | 19 | $45 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Morgantown
- David SaldivarMorgantown$28K
- Violet ShacklefordMorgantown$17K
- Brian SlaterMorgantown$6K
- Benjamin BirneyMorgantown$3K
- Trey VanekMorgantown$2K
- Richard BowmanMorgantown$2K
- Nicole HollisMorgantown$1K
- Onyechi MegafuHuntington$37K
- Lucas BraceroCharleston$24K
- Muhammad MaazHuntington$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.